THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL

VOSE J COLCHER D BIERMAN P GOBAR L HOHENSTEIN M AUGUSTINE S GOLDENBERG D TEMPERO M ARMITAGE J

J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 7-7

NO

Oncology,"Radiology,Nuclear Medicine & Medical Imaging","Pharmacology & Pharmacy","Medicine, Research & Experimental

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS → ACNP

10849785

13

1

1998

7 - 7

ISI

1084-9785(1998)13:1<7:TORN(W>2.0.ZU;2-L